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Objective. The aim of this study was to determine the protective effect of p-coumaric acid (p-CA) against toluene-induced 
hepatotoxicity, nephrotoxicity and neurotoxicity in rats. Materials and methods. A total of 32 Sprague-Dawley male rats, 
8 in each group, were used. 4 groups were formed as control, toluene, p-CA and toluene+p-CA. Animals in the control 
group, toluene group and p-CA group were given 0.9% NaCl, 0.9 mg/kg b.w toluene and 100 mg/kg b.w p-CA orally for 
21 days, respectively. The animals in toluene+p-CA group were received p-CA for 3 days and from day 4, toluene and 
p-CA were applied together daily until day 25. On the 25th day, the study was terminated, blood and tissue samples were 
collected. Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and creatinine levels in serum, glutathione 
peroxidase (GSH-Px) activity and malondialdehyde (MDA) and glutathione (GSH) levels in the tissue samples were 
determined. Results. In this study, it was determined that there were significant increases in ALT and AST activities, and 
creatinine levels in toluene-induced group compared to control group. Moreover, there was a decrease in the GSH-Px 
activities and GSH levels, and an increase in the MDA levels compared to the control group. However, in the toluene+p-CA 
group, significant decreases in aminotransferases activities, creatinine and MDA levels, and significant increases in GSH-
Px activities and GSH levels were determined compared to the toluene group. Conclusions. It has been determined that 
p-CA has a protective effect against toluene-induced hepatotoxicity, nephrotoxicity and neurotoxicity.
Keywords: Brain; coumaric acid; kidney; liver; oxidative stress; toluene (Source: CAB).
 
RESUMEN
Objetivo. El objetivo de este estudio ha sido determinar el efecto protector del ácido p-cumárico (p-CA) contra la 
hepatotoxicidad, nefrotoxicidad y neurotoxicidad inducida por tolueno en ratas. Materiales y métodos. Se utilizaron un 
total de 32 ratas macho Sprague-Dawley, 8 en cada grupo. Se formaron 4 grupos: el de control, tolueno, p-CA y tolueno 
+ p-CA. Los animales del grupo de control, el grupo de tolueno y el grupo de p-CA recibieron NaCl al 0,9%, 0,9 mg / kg 
de peso corporal de tolueno y 100 mg / kg de peso corporal de p-CA por vía oral durante 21 días, respectivamente. Los 
animales del grupo tolueno + p-CA recibieron p-CA durante 3 días y desde el día 4, el tolueno y el p-CA se aplicaron juntos 
diariamente hasta el día 25. El día 25, se terminó el estudio, se tomaron muestras de sangre y tejido. Se determinaron los 
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niveles de aspartato aminotransferasa (AST), alanina aminotransferasa (ALT) y creatinina en suero, actividad de glutatión 
peroxidasa (GSH-Px) y niveles de malondialdehído (MDA) y glutatión (GSH) en las muestras de tejido. Resultados. En 
este estudio, se determinó que hubo aumentos significativos en las actividades de ALT y AST, y los niveles de creatinina en 
el grupo inducido por tolueno en comparación con el grupo de control. Además, hubo una disminución en las actividades 
de GSH-Px y los niveles de GSH, y un aumento en los niveles de MDA en comparación con el grupo de control. Sin embargo, 
en el grupo de tolueno + p-CA, se observaron disminuciones significativas en las actividades de las aminotransferasas, 
niveles de creatinina y MDA, y aumentos significativos en las actividades de GSH-Px y los niveles de GSH en comparación 
con el grupo de tolueno. Conclusiones. Se ha determinado que el p-CA tiene un efecto protector contra la hepatotoxicidad, 
nefrotoxicidad y neurotoxicidad inducidas por el tolueno.
Palabras clave: Cerebro; ácido cumarico; riñón; hígado; estrés oxidativo; tolueno (Fuente: CAB).
INTRODUCTION
Organic solvents such as toluene, benzene and xylene pose a great risk to public health as they are widely used in the 
industry. Solvents are a class of liquid organic chemicals which have high lipophilicity and volatility (1,2). Toluene, also 
known as toluol, methylbenzene and methacide, is a colorless, fragrant organic hydrocarbon solvent used widely in 
fabrication of industrial supplies and synthesis of various products. It is an important component of chemical paints, 
adhesives, coatings, varnishes, printing inks, fuel additives, glues, thinners and plastics (3,4). Toluene is found in liquid 
form at room temperature, but because of its low vapor pressure, it can be easily volatilized (5,6). As a result of widespread 
use of toluene, there are both occupational and non-occupational exposures (7). Exposure to toluene can be occured by 
a variety of ways, such as consumption with drinking water, food, consumer products or occupational exposure and 
chemical abuse (8). Toluene has lipophilic properties and is rapidly absorbed after being taken orally or by inhalation and 
tends to accumulate in adipose tissue and lipid-rich organs such as the brain, kidney, liver, intestines, spleen and adrenal 
glands (5,9). Toluene is rapidly transformed to benzyl alcohol in the liver by the microsomal enzyme system. Then benzyl 
alcohol turns into benzoic acid. Benzoic acid reacts with glycine or glucuronic acid. It is excreted in the urine as hippuric 
acid or benzol glucuronides. A small part of the toluene turns into o- and p-cresol (6). When living organisms are exposed 
to toluene, the formation of free oxygen radicals increases and cellular damage occurs. In physiological conditions of 
living organisms, reactive oxygen species (ROS) are produced. Antioxidant defense systems reduce these ROS and prevent 
damage caused by them. While toluene is metabolized in the liver, it generates different ROS including singlet oxygen (O2), superoxide anion (O2-), hydrogen peroxide (H2O2) and hydroxyl radical (OH-) (10). Free oxygen radicals are molecules containing at least one unpaired electron in its outer orbit. Free oxygen radicals react with nucleic acids, free amino acids, 
proteins, fats, carbohydrates, causing irreversible damage. Thus, they create pathological changes in the cell membrane, 
cell organelles and DNA (11,12,13).
p-coumaric acid (p-CA) is a phenolic compound usually found in a variety of vegetables (potatoes, tomatoes, peas), fruits 
(apples, pears, pineapples), foods and beverages (chocolate, tea, coffee, wine, beer) (14,15).  p-CA has been reported to 
have an antioxidant effect by binding metal ions, cleaning reactive oxygen and reactive nitrogen radicals, rearranging 
endogenous antioxidant enzymes or repairing oxidative damage in biomolecules (14,16). The aim of this study was to 
determine the protective effect of p-CA on toluene-induced hepatotoxicity, nephrotoxicity and neurotoxicity in rats.
MATERIALS AND METHODS
Ethical aspects. The rats used in the present study were obtained from Burdur Mehmet Akif Ersoy University Experimental 
Animal Production and Experimental Research Center and experimental applications were made in the same place. The 
research was carried out according to decision at the meeting of the Animal Experiments Local Ethics Committee of 
Burdur Mehmet Akif Ersoy University, Turkey (Ethics No:126-01/04/2015). 
Experimental animals & design. In this study, a total of 32 male 10-12 weeks old Sprague-Dawley rats weighing 
approximately 200-300 g were divided into four groups of 8 animals each (Table 1). All animals were given ad libitum pellet 
feed and water. The doses of toluene (5) and p-CA (14,15) to be given to animals were determined in the light of previous 
studies. The study was terminated at the 25th day. All animals were anesthetized with 2-3% isoflurane (inhalation). The 
animals were euthanized by cervical dislocation under anesthesia. Blood and tissue samples were collected.
Table 1. The design of experimental study. 
Groups Treatments Days
Control 0.9 % NaCl by gavage (1 mg/kg) 4-24.
Toluene 0.9 mg/kg b.w toluene by gavage 4-24.
p-CA 100 mg/kg/b.w p-CA by gavage 4-24.
Toluene+p-CA 3 days ago 100 mg/kg/b.w p-CA by gavageFrom day 4, 100 mg/kg/b.w p-CA by gavage + 0.9 mg/kg b.w toluene by gavage 1-24.
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Biochemical estimations. Blood samples were taken into tubes with and without EDTA. They were centrifuged for 
10 minutes at 4000 rpm. Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and creatinine in blood 
were measured in Gesan Chem 200 autoanalyzer (Gesan chem 200 Gesan Production srl, Campobello, Italy). Kinetic UV 
optimized The International Federation of Clinical Chemistry (IFCC) methods were used in ALT and AST measurements 
and Jaffè method was used in creatinine measurement (17). 
Preparation of tissue samples. The tissue samples were prepared for homogenization by washing with 0.9% ice-cold 
isotonic saline. Buffer solution was prepared as follows: 140 mM KCl, 10 mM NaHCO3, 3 mM KH2PO4 and 2 mM K2HPO4; dissolved in 950 ml of deionized water and adjusted to pH 7.2 with NaOH (5N) and completed to 1000 ml. The tissue 
samples were homogenized with the buffer (1/10 w/v). For 45 minutes at 15000 rpm and 4°C, homogenates were 
centrifuged, supernatants were separated and kept at -20°C until analysis.
Estimations of antioxidant/oxidant parameters in brain, kidney and liver tissues. Glutathione (GSH) levels were 
measured using the method reported by Sedlak and Lindsay (18) and expressed in µmol/g protein. Glutathione peroxidase 
(GSH-Px) activities were measured according to the method reported by Paglia and Valentine (19) and expressed in 
U/g protein. Malondialdehyde (MDA) levels were measured according to the method reported by Ohkawa et al (20) and 
expressed in µmol/g protein. Determination of total protein was performed based on the Biuret method reported by 
Gornall et al (21).
Statistical evaluation. Data of the study were evaluated using the “SPSS 22.0” program (IBM SPSS Statistics for 
Windows, Version 22.0. Armonk, NY). Results are expressed with arithmetic mean ± standard error of the mean (SEM). 
To determine the comparisons of means between groups, one-way analysis of variance (ANOVA) was applied. For 
determination of the differences between the groups, Tukey’s post hoc test was used. p<0.05 was considered as statistically 
significant.
RESULTS 
Significant (p<0.05) increases in serum AST and ALT activities, and creatinine level were detected in toluene group 
compared to the control. In the toluene+p-CA group, significant (p<0.05) decreases in the activities of AST, ALT and level 
of creatinine, which were increased when toluene was administered alone, were determined. No significant changes were 
found in the group where p-CA was administered alone compared to the control (Table 2).
Table 2. Serum AST, ALT and creatinine activities of the groups.
Parameters
Groups
Control Toluene p-CA Toluene+p-CA
AST 154.57±2.84a 327.42±6.49c 150.69±9.98a 243.17±4.76b
ALT 83.90±0.82a 147.33±5.38c 85.34±2.34a 96.42±0.99b
Creatinine 0.50±0.02a 2.22±0.03c 0.57±0.03a 0.89±0.03b
* Values are expressed as arithmetic mean ± SEM.
** (a, b, c) shows differences between groups in the same line, p<0.05
p-CA: p-coumaric acid; AST: Aspartate aminotransferase (U/L); ALT: Alanine aminotransferase (mg/dL); Creatinine: mg/dL
Significant (p<0.05) increases in the levels of MDA and significant (p<0.05) decreases in the levels of GSH and the activities 
of GSH-Px were detected in the brain, kidney and liver tissues in the toluene group, compared to the control group. In the 
toluene+p-CA group, significant (p<0.05) decreases in the levels of MDA and significant (p<0.05) increases in the levels 
of GSH and the activities of GSH-Px were detected in the brain, kidney and liver tissues compared to toluene group (Table 
3,4,5). 
Table 3. GSH and MDA levels and GSH-Px activities in liver tissues of the groups.
Parameters
Groups
Control Toluene p-CA Toluene+p-CA
GSH 14.02±0.65c 6.34±0.38a 14.56±0.64c 10.03±0.29b
GSH-Px 132.08±7.22c 59.80±3.33a 114.47±6.10c 88.32±1.65b
MDA 4.09±0.07a 9.86±0.69c 3.73±0.22a 6.38±0.48b
* Values are expressed as arithmetic mean ± SEM.
** (a, b, c) shows differences between groups in the same line, p<0.05
p-CA: p-coumaric acid; GSH: Glutathione (µmol/g protein); GSH-Px: Glutathione peroxidase (U/g protein); MDA: Malondialdehyde (µmol/g protein)
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Table 4. GSH and MDA levels and GSH-Px activities in kidney tissues of the groups.
Parameters
Groups
Control Toluene p-CA Toluene+p-CA
GSH 0.87±0.02c 0.40±0.05a 0.75±0.04c 0.57±0.04b
GSH-Px 10.90±0.41d 5.21±0.54a 9.45±0.11c 6.97±0.28b
MDA 5.75±0.43a 12.63±0.38c 4.92±0.44a 7.80±0.49b
* Values are expressed as arithmetic mean ± SEM.
** (a, b, c, d) shows differences between groups in the same line, p<0.05
p-CA: p-coumaric acid; GSH: µmol/g protein; GSH-Px: U/g protein;  MDA: µmol/g protein
Table 5. GSH and MDA levels and GSH-Px activities in brain tissues of the groups.
Parameters
Groups
Control Toluene p-CA Toluene+p-CA
GSH 0.91±0.05c 0.23±0.03a 0.82±0.05c 0.64±0.02b
GSH-Px 16.53±1.94d 4.14±0.16a 10.72±0.38c 8.64±0.42b
MDA 7.27±0.39a 16.29±0.70c 6.34±0.35a 11.00±0.48b
* Values are expressed as arithmetic mean ± SEM.
** (a, b, c ,d) shows differences between groups in the same line, p<0.05
p-CA: p-coumaric acid;  GSH: µmol/g protein;  GSH-Px: U/g protein;  MDA: µmol/g protein
DISCUSSION
The findings of the present study revealed that p-CA has a protective effect aganist toluene-induced tisssue damage. 
In this study, it was determined that toluene given to rats at a dose of 0.9 mg/kg b.w for 21 days significantly changed 
the oxidant/antioxidant balance and increased aminotranferases activities and creatinine level. Results of this study 
showed that toluene could induce oxidative stress in the brain, liver and kidney tissues. On the other hand, p-CA revealed 
protective effects by improving the antioxidant system defence, suppressing oxidative stress in tissues.
The liver is the primary organ in which drugs and xenobiotics are primarily metabolized. In the present study, significant 
(p<0.05) decreases in GSH level and GSH-Px activity; a significant (p<0.05) increase in MDA level were detected in liver 
samples of toluene group compared to control. In previous studies (22, 23, 24, 25) it was emphasized that toluene causes 
decrease in the efficiency of the antioxidant systems and increases lipid peroxidation in liver tissues. Mattia et al (22,23) 
administered toluene (1.5 mg/kg intraperitoneally) to rats and detected a significant (p<0.05) decrease in GSH level 
and increase in MDA level in the liver tissues. El-Nabi Kamel and Shehata (24) gave toluene (650 mg/kg single dose) 
to rats and found a significant (p<0.05) increase in MDA level and decrease in GSH level in the toluene group. Tas et al 
(25) reported that liver MDA level in the toluene group were significantly (p<0.05) higher than in control group. In the 
present study, in liver samples significant (p<0.05) increases in GSH-Px activity and GSH level and decrease in MDA level 
were detected in toluene+p-CA compared to toluene group. There are studies in which p-CA is used as a protector against 
oxidative damage induced by different agents. Similar to the current study, p-CA in liver tissues increased GSH levels and 
GSH-Px activities, and decreased MDA levels in previous studies (26,27,28).
The kidney is the primary excretion organ for most xenobiotics. In this study, MDA level was significantly (p<0.05) 
increased and GSH-Px activity and GSH level were significantly (p<0.05) decreased in toluene group when compared to 
the control group in the kidney tissues. El-Nabi Kamel and Shehata (24) administered toluene (650 mg/kg b.w) to rats and 
found a significant (p<0.05) increase in MDA level and a significant (p<0.05) decrease in GSH level in the toluene group. 
Ahmadizadeh et al (8) reported that rats administered to rats determined a significant (p<0.05) decrease in GSH level in 
kidney tissues compared to the control. Afravy et al (3) gave toluene (300, 600 and 900 mg/kg intraperitoneally) to the 
rats and investigated on toluene-induced kidney damage. In the toluene group compared to the control, the researchers 
stated that there was a significant (p<0.05) dose-dependant increase in MDA level. The results of the present study are 
agreed with those of previous studies. In the present study, in kidney samples significant (p<0.05) increases in GSH-Px 
activity and GSH level and decrease in MDA level were detected in the toluene+p-CA group compared to toluene group. 
Similar to the present study, p-CA in kidney tissues increased GSH levels and GSH-Px activities and decreased in MDA 
levels in previous studies (26,27,28,29,30).  
Brain is one of the target organs of toluene-induced toxicity due to its lipid-rich characteristics (31). In this study, in 
brain samples significant (p<0.05) increase in MDA level and significant (p<0.05) decreases in GSH-Px activity and GSH 
level were detected in toluene group compared to the control group. Mattia et al (22) administered toluene (a single 
intraperitoneal dose of 1.5 mg/kg b.w) to rats and determined a significant (p<0.05) decrease in GSH levels in brain 
tissues (hippocampus, cerebellum and striatum). Coskun et al (32) gave toluene (3000 ppm by inhalation for 16 weeks, 
8 hour/day, 6 day/week) to rats and detected significant (p<0.05) decrease in GSH-Px activity and significant (p<0.001) 
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increase in MDA level in sciatic nerve tissues of rats. El-Nabi Kamel and Shehata (24) administered toluene (650 mg/kg 
a single dose) to rats and found a significant (p<0.05) decrease in GSH level and a significant (p<0.05) increase in MDA 
level depending on time in the toluene group. Kodavanti et al (33) treated rats with toluene (4, 12 and 24 months old rats 
with 0, 0.65 or 1 g/kg b.w single oral) and stated that there was a significant (p<0.001) decrease in GSH-Px activities in 
striatum tissues of 24-month-old rats and hippocampus tissues of toluene-treated 4-month-old rats. Abdel-Salam et al. 
(31) administered toluene (900 mg/kg b.w/day intraperitoneally) to rats and determined a significant (p<0.05) decrease 
in GSH level and a significant (p<0.05) increase in MDA level compared to control group. Montes et al. (34) treated mice 
with toluene (0 or 4000 ppm) for 4 weeks and 30 min in a day by inhalation. They indicated that there was a significant 
(p<0.05) decrease in GSH/GSSG level in both hippocampus and prefrontal cortex tissues of toluene-treated mice. In the 
present study, in brain samples significant (p<0.05) decrease in MDA level and significant (p<0.05) increases in GSH-Px 
activity and GSH level were detected in the toluene+p-CA group compared to toluene group. Similar to the present study, 
p-CA in brain tissues increased GSH levels and GSH-Px activities and decreased in MDA levels in previous studies (35,36). 
In organ damage, significant changes occur in biochemical parameters. Increases in serum ALT and AST enzyme levels 
indicate liver damage. Creatinine and urea are markers of kidney damage or failure. Serum aminotransferase levels 
increase due to hepatitis, cirrhosis, liver cancer, and toxicity of drugs and various xenobiotics (37). In this study, in the 
toluene group compared to the control, significant (p<0.05) increases in serum ALT and AST activities and creatinine 
level were detected. Bae and Yoon (38) stated that toluene caused a significant (p<0.01) increase in ALT and AST levels in 
rat liver tissues. Tas et al. (25) administered 3000 ppm/hour/day toluene with inhalation to male rats for 4 weeks. It is 
stated that levels of serum ALT and AST were significantly (p<0.05) high in toluene-treated group. Moro et al (39) found 
that ALT and AST values were significantly (p<0.05 and p<0.001, respectively) higher in subjects exposed to toluene 
compared to control. Meydan et al (40) stated that there was a significant (p<0.001) increase in serum creatinine levels in 
toluene group compared to control. Afravy et al (3) applied different doses of toluene to rats (600 and 900) and reported 
a significant (p<0.05) dose-dependant increase in creatinine levels of toluene group. Meydan et al (37) reported that in 
serum ALT and AST levels there was a significant (p<0.001) increase in toluene group compared to the control group. 
These studies are in line with our results. In the present study, ALT and AST activities in the toluene+p-CA group were 
significantly (p<0.05) higher than in the toluene group.  Similar to the present study, p-CA in serum samples decreased 
ALT and AST activities, and cretainine level (41,42,43,44).  
In this study, it was found that the organs most sensitive to lipid peroxidation are brain, kidney and liver, respectively. This 
shows that toluene, which is a quite lipophilic solvent, accumulates primarily in lipid-rich tissues. The results of this study 
showed that toluene caused oxidative stress in brain, kidney and liver tissues at the dose administered and the period 
indicated. Also, it was found that p-CA has not any toxic effects on these tissues. As a result, it has been determined that 
p-CA (at the indicated dose and period) has a protective effect against toluene-induced hepatotoxicity, nephrotoxicity and 
neurotoxicity.
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